D-Con en es it fr

D-Con Brand names, D-Con Analogs

D-Con Brand Names Mixture

  • No information avaliable

D-Con Chemical_Formula


D-Con RX_link


D-Con fda sheet


D-Con msds (material safety sheet)


D-Con Synthesis Reference

Stahmann, et al., U.S. Pat. 2,427,578 (1947)

D-Con Molecular Weight

308.328 g/mol

D-Con Melting Point

161 oC

D-Con H2O Solubility

17 mg/L

D-Con State


D-Con LogP


D-Con Dosage Forms

Powder for solution; Tablet

D-Con Indication

For the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia, arterial embolism and thrombosis.

D-Con Pharmacology

Warfarin, a coumarin anticoagulant, is a racemic mixture of two active isomers. It is used in the prevention and treatment of thromboembolic disease including venous thrombosis, thromboembolism, and pulmonary embolism as well as for the prevention of ischemic stroke in patients with atrial fibrillation (AF).

D-Con Absorption

No information avaliable

D-Con side effects and Toxicity

LD50=374 (orally in mice)

D-Con Patient Information

No information avaliable

D-Con Organisms Affected

Humans and other mammals